31 August 2023: Clinical Research
Associations Between Mean Platelet Volume and Various Factors in Type 2 Diabetes Patients: A Single-Center Study from Poland
Karolina Marta Gacuta 1ABCDEFG* , Olga Martyna Koper-Lenkiewicz 2ABCDEFG* , Anna Justyna Milewska 3CD , Magdalena Ćwiklińska-Dworakowska 4D , Joanna Matowicka-Karna 2D , Joanna Kamińska 2ABDEFGDOI: 10.12659/MSM.941109
Med Sci Monit 2023; 29:e941109
Figure 2 Comparison of TPO, IL-6, sP-selectin, and sCD40L concentration results in type 2 diabetes patients and the control group(A) The median TPO concentration in patients with type 2 diabetes did not differ from that of the control group (P=0.7210). (B) The median IL-6 concentration in patients with type 2 diabetes was significantly higher than that of the control group (P<0.0001). (C) The median sP-selectin concentration in patients with type 2 diabetes was significantly higher than that of the control group (P=0.0008). (D) The median sCD40L concentration in patients with type 2 diabetes was significantly higher than that of the control group (P=0.0010). IL-6 – interleukin 6; sCD40L – soluble form of CD40L; sP-selectin – soluble form of selectin P; TPO – thrombopoietin. Statistical significance: *** P≤0.001, **** P≤0.0001. The figure was created with the use of the GraphPad Prism 8.0 software (GraphPad Software, San Diego, CA, USA).